- Home
- CRNT vs MDXH Comparison
CRNT vs MDXH Comparison
Compare CRNT & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRNT | MDXH |
|---|---|---|
| Founded | 1996 | 2003 |
| Country | Israel | Belgium |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 189.7M | 167.8M |
| IPO Year | 2000 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CRNT | MDXH |
|---|---|---|
| Price | $2.19 | $3.45 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $4.00 | ★ $7.67 |
| AVG Volume (30 Days) | ★ 550.5K | 117.5K |
| Earning Date | 02-10-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $363,330,000.00 | $103,069,000.00 |
| Revenue This Year | N/A | $23.34 |
| Revenue Next Year | $5.06 | $22.98 |
| P/E Ratio | $140.03 | ★ N/A |
| Revenue Growth | N/A | ★ 21.68 |
| 52 Week Low | $1.82 | $1.35 |
| 52 Week High | $5.73 | $5.33 |
Technical Indicators
Market Signals| Indicator | CRNT | MDXH |
|---|---|---|
| Relative Strength Index (RSI) | 57.43 | 47.72 |
| Support Level | $2.05 | $3.20 |
| Resistance Level | $2.15 | $3.58 |
| Average True Range (ATR) | 0.07 | 0.19 |
| MACD | 0.02 | 0.05 |
| Stochastic Oscillator | 97.92 | 70.00 |
Price Performance
Historical ComparisonAbout CRNT Ceragon Networks Ltd.
Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and wide distribution of its business, providing high-capacity wireless connectivity solutions to markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the key revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.
About MDXH MDxHealth SA
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.